FDA Advisory Committee Recommends Approval of Novo Nordisk’s Liraglutide for Obesity September 30, 2014 Filed under: Trends-in-Medicine
FDA Committee Recommends Approval of NPS Pharmaceuticals’ Natpara for Hypoparathyroidism September 30, 2014 Filed under: Trends-in-Medicine